Develops RNA medicines for obesity and liver diseases.
Dec 2025Revenue $42.7M/yrExpenses $258M/yr
No trendCash runway ≈ 1.9 years from Jun 2026
Figures by year
When will Wave Life Sciences be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $42.7M and expenses $258M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $42.7M | $258M | −$215M |
| Dec 2024 | $108M | $219M | −$110M |
| Dec 2023 | $113M | $181M | −$68.0M |
| Dec 2022 | $3.65M | $166M | −$163M |
| Dec 2021 | $41.0M | $168M | −$127M |
| Dec 2020 | $20.1M | $173M | −$153M |
| Dec 2019 | $16.0M | $224M | −$208M |
| Dec 2018 | $14.4M | $174M | −$160M |
| Dec 2017 | $3.89M | $106M | −$102M |
| Dec 2016 | $1.09M | $56.8M | −$55.7M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.